A novel ellipticine analog as a therapeutic candidate for acute myeloid leukemia
Ended Project Grant Awarded Last action
- Award ID
- R43CA141915
- Recipient
-
Cleveland Leukemia Therapeutics LLC UEI KD8EBA9NYNN8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $153,770
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Cleveland, OH 44106, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43CA141915?
R43CA141915 was awarded to Cleveland Leukemia Therapeutics LLC by National Institutes of Health (Department of Health and Human Services) on July 13, 2009.
How much is award R43CA141915 worth?
$153,770 has been obligated on R43CA141915.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award